A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

REFERENCES

• Miller KD, Ostrom QT, Kruchko C, Patil N, Tihan T, Cioffi G, Fuchs HE, Waite KA, Jemal A, Siegel RL, et al. Brain and other central nervous system tumor statistics, 2021. CA Cancer J Clin. 2021;71:381–406. doi:10.3322/caac.21693.
   PubMed Web of Science ®Google Scholar
• Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359:492–507. doi:10.1056/NEJMra0708126.
   PubMed Web of Science ®Google Scholar
• Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE, Fuller GN. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet. 2000;25:55–57. doi:10.1038/75596.
   PubMed Web of Science ®Google Scholar
• Chen J, Zeng Y, Wu R, Xuan Y, Jiang M, Teng H. Decreased DUSP26 expression promotes malignant behavior in glioblastoma cells via deregulation of MAPK and Akt signaling pathway. Front Oncol. 2021;11:676647. doi:10.3389/fonc.2021.676647.
   PubMed Web of Science ®Google Scholar
• Ou A, Ott M, Fang D, Heimberger AB. The role and therapeutic targeting of JAK/STAT signaling in glioblastoma. Cancers. 2021;13:437. doi:10.3390/cancers13030437.
   PubMed Web of Science ®Google Scholar
• Nešović M, Divac Rankov A, Podolski-Renić A, Nikolić I, Tasić G, Mancini A, Schenone S, Pešić M, Dinić J. Src inhibitors pyrazolo[3,4-d]pyrimidines, Si306 and Pro-Si306, inhibit focal adhesion kinase and suppress human glioblastoma invasion in vitro and in vivo. Cancers. 2020;12:1570. doi:10.3390/cancers12061570.
   PubMed Web of Science ®Google Scholar
• Ito Y, Fukui M, Kanda M, Morishita K, Shoji Y, Kitao T, Hinoi E, Shirahase H. Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in mice. J Pharmacol Sci. 2018;137:38–46. doi:10.1016/j.jphs.2018.03.001.
   PubMed Web of Science ®Google Scholar
• Sharma B, Xie L, Yang F, Wang W, Zhou Q, Xiang M, Zhou S, Lv W, Jia Y, Pokhrel L, et al. Recent advance on PTP1B inhibitors and their biomedical applications. Eur J Med Chem. 2020;199:112376. doi:10.1016/j.ejmech.2020.112376.
   PubMed Web of Science ®Google Scholar
• Prabhakar PK, Sivakumar PM. Protein tyrosine phosphatase 1B inhibitors: a novel therapeutic strategy for the management of type 2 diabetes mellitus. Curr Pharm Des. 2019;25:2526–2539. doi:10.2174/1381612825666190716102901.
   PubMed Web of Science ®Google Scholar
• Lessard L, Stuible M, Tremblay ML. The two faces of PTP1B in cancer. Biochim Biophys Acta. 2010;1804:613–619. doi:10.1016/j.bbapap.2009.09.018.
   PubMed Web of Science ®Google Scholar
• Bjorge JD, Pang A, Fujita DJ. Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines. J Biol Chem. 2000;275:41439–41446. doi:10.1074/jbc.M004852200.
   PubMed Web of Science ®Google Scholar
• Dadke S, Chernoff J. Protein-tyrosine phosphatase 1B mediates the effects of insulin on the actin cytoskeleton in immortalized fibroblasts. J Biol Chem. 2003;278:40607–40611. doi:10.1074/jbc.M306772200.
   PubMed Web of Science ®Google Scholar
• Arias-Romero LE, Saha S, Villamar-Cruz O, Yip S-C, Ethier SP, Zhang Z-Y, Chernoff J. Activation of Src by protein tyrosine phosphatase 1B is required for ErbB2 transformation of human breast epithelial cells. Cancer Res. 2009;69:4582–4588. doi:10.1158/0008-5472.CAN-08-4001.
   PubMed Web of Science ®Google Scholar
• Yamanashi Y, Baltimore D. Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok. Cell. 1997;88:205–211. doi:10.1016/s0092-8674(00)81841-3.
   PubMed Web of Science ®Google Scholar
• Kashige N, Carpino N, Kobayashi R. Tyrosine phosphorylation of p62dok by p210bcr-abl inhibits RasGAP activity. Proc Natl Acad Sci USA. 2000;97:2093–2098. doi:10.1073/pnas.040547997.
   PubMed Web of Science ®Google Scholar
• Julien SG, Dubé N, Read M, Penney J, Paquet M, Han Y, Kennedy BP, Muller WJ, Tremblay ML. Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis. Nat Genet. 2007;39:338–346. doi:10.1038/ng1963.
   PubMed Web of Science ®Google Scholar
• Bentires-Alj M, Neel BG. Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer. Cancer Res. 2007;67:2420–2424. doi:10.1158/0008-5472.CAN-06-4610.
   PubMed Web of Science ®Google Scholar
• Ren S, Rollins BJ. Cyclin C/cdk3 promotes Rb-dependent G0 exit. Cell. 2004;117:239–251. doi:10.1016/s0092-8674(04)00300-9.
   PubMed Web of Science ®Google Scholar
• Lu J, Zhang ZL, Huang D, Tang N, Li Y, Peng Z, Lu C, Dong Z, Tang F. Cdk3-promoted epithelial-mesenchymal transition through activating AP-1 is involved in colorectal cancer metastasis. Oncotarget. 2016;7:7012–7028. doi:10.18632/oncotarget.6875.
   PubMedGoogle Scholar
• Karlsson-Rosenthal C, Millar JBA. Cdc25: mechanisms of checkpoint inhibition and recovery. Trends Cell Biol. 2006;16:285–292. doi:10.1016/j.tcb.2006.04.002.
   PubMed Web of Science ®Google Scholar
• Boutros R, Dozier C, Ducommun B. The when and wheres of CDC25 phosphatases. Curr Opin Cell Biol. 2006;18:185–191. doi:10.1016/j.ceb.2006.02.003.
   PubMed Web of Science ®Google Scholar
• Qin Z, Pandey NR, Zhou X, Stewart CA, Hari A, Huang H, Stewart AFR, Brunel JM, Chen H-H. Functional properties of Claramine: a novel PTP1B inhibitor and insulin-mimetic compound. Biochem Biophys Res Commun. 2015;458:21–27. doi:10.1016/j.bbrc.2015.01.040.
   PubMed Web of Science ®Google Scholar
• Ferrari E, Tinti M, Costa S, Corallino S, Nardozza AP, Chatraryamontri A, Ceol A, Cesareni G, Castagnoli L. Identification of new substrates of the protein-tyrosine phosphatase PTP1B by Bayesian integration of proteome evidence. J Biol Chem. 2011;286:4173–4185. doi:10.1074/jbc.M110.157420.
   PubMed Web of Science ®Google Scholar
• Ren L, Chen X, Luechapanichkul R, Selner NG, Meyer TM, Wavreille A-S, Chan R, Iorio C, Zhou X, Neel BG, et al. Substrate specificity of protein tyrosine phosphatases 1B, RPTPα, SHP-1, and SHP-2. Biochemistry. 2011;50:2339–2356. doi:10.1021/bi1014453.
   PubMed Web of Science ®Google Scholar
• Schwarz JJ, Grundmann L, Kokot T, Kläsener K, Fotteler S, Medgyesi D, Köhn M, Reth M, Warscheid B. Quantitative proteomics identifies PTP1B as modulator of B cell antigen receptor signaling [Internet]. Biochemistry. 2021 10.1101/2021.03.30.437652.
   Google Scholar
• Haj FG, Markova B, Klaman LD, Bohmer FD, Neel BG. Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B. J Biol Chem. 2003;278:739–744. doi:10.1074/jbc.M210194200.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang B, Zhang P, Lian L, Li L, Qiu Z, Qian K, Chen A, Liu Q, Jiang Y, et al. Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells. PLoS One. 2019;14:e0217181. doi:10.1371/journal.pone.0217181.
   PubMed Web of Science ®Google Scholar
• Liu Z, Yang S, Li W, Dong S, Zhou S, Xu S. circRNA_141539 can serve as an oncogenic factor in esophageal squamous cell carcinoma by sponging miR-4469 and activating CDK3 gene. Aging. 2021;13:12179–12193. doi:10.18632/aging.103071.
   PubMedGoogle Scholar
• Singh S, Singh H, Tuknait A, Chaudhary K, Singh B, Kumaran S, Raghava GPS. PEPstrMOD: structure prediction of peptides containing natural, non-natural and modified residues. Biol Direct. 2015;10:73. doi:10.1186/s13062-015-0103-4.
   PubMed Web of Science ®Google Scholar
• Alekseenko A, Ignatov M, Jones G, Sabitova M, Kozakov D. Protein-protein and protein-peptide docking with ClusPro server. Methods Mol Biol. 2020;2165:157–174.
   PubMedGoogle Scholar
• Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C, Beglov D, Vajda S. The ClusPro web server for protein-protein docking. Nat Protoc. 2017;12:255–278. doi:10.1038/nprot.2016.169.
   PubMed Web of Science ®Google Scholar
• Wiesmann C, Barr KJ, Kung J, Zhu J, Erlanson DA, Shen W, Fahr BJ, Zhong M, Taylor L, Randal M, et al. Allosteric inhibition of protein tyrosine phosphatase 1B. Nat Struct Mol Biol. 2004;11:730–737. doi:10.1038/nsmb803.
   PubMed Web of Science ®Google Scholar
• Brown NR, Noble MEM, Lawrie AM, Morris MC, Tunnah P, Divita G, Johnson LN, Endicott JA. Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity. J Biol Chem. 1999;274:8746–8756. doi:10.1074/jbc.274.13.8746.
   PubMed Web of Science ®Google Scholar
• Ye X, Zhu C, Harper JW. A premature-termination mutation in the Mus musculus cyclin-dependent kinase 3 gene. Proc Natl Acad Sci USA. 2001;98:1682–1686. doi:10.1073/pnas.98.4.1682.
   PubMed Web of Science ®Google Scholar
• Hagting A, Karlsson C, Clute P, Jackman M, Pines J. MPF localization is controlled by nuclear export. EMBO J. 1998;17:4127–4138. doi:10.1093/emboj/17.14.4127.
   PubMed Web of Science ®Google Scholar
• Yip S-C, Saha S, Chernoff J. PTP1B: a double agent in metabolism and oncogenesis. Trends Biochem Sci. 2010;35:442–449. doi:10.1016/j.tibs.2010.03.004.
   PubMed Web of Science ®Google Scholar
• Villamar-Cruz O, Loza-Mejía MA, Arias-Romero LE, Camacho-Arroyo I. Recent advances in PTP1B signaling in metabolism and cancer. Biosci Rep. 2021;41:BSR20211994. doi:10.1042/BSR20211994.
   PubMed Web of Science ®Google Scholar
• Wiener JR, Kerns BJ, Harvey EL, Conaway MR, Iglehart JD, Berchuck A, Bast RC. Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression. J Natl Cancer Inst. 1994;86:372–378. doi:10.1093/jnci/86.5.372.
   PubMedGoogle Scholar
• Zhu S, Bjorge JD, Fujita DJ. PTP1B contributes to the oncogenic properties of colon cancer cells through Src activation. Cancer Res. 2007;67:10129–10137. doi:10.1158/0008-5472.CAN-06-4338.
   PubMed Web of Science ®Google Scholar
• Lessard L, Labbé DP, Deblois G, Bégin LR, Hardy S, Mes-Masson A-M, Saad F, Trotman LC, Giguère V, Tremblay ML. PTP1B is an androgen receptor-regulated phosphatase that promotes the progression of prostate cancer. Cancer Res. 2012;72:1529–1537. doi:10.1158/0008-5472.CAN-11-2602.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu B, Chen X, Su L, Wu P, Wu J, Zhu Z. PTP1B expression contributes to gastric cancer progression. Med Oncol. 2012;29:948–956. doi:10.1007/s12032-011-9911-2.
   PubMed Web of Science ®Google Scholar
• Jin T, Li D, Yang T, Liu F, Kong J, Zhou Y. PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival. Oncol Rep. 2019;42:717–725. doi:10.3892/or.2019.7180.
   PubMed Web of Science ®Google Scholar
• Liu H, Wu Y, Zhu S, Liang W, Wang Z, Wang Y, Lv T, Yao Y, Yuan D, Song Y. PTP1B promotes cell proliferation and metastasis through activating src and ERK1/2 in non-small cell lung cancer. Cancer Lett. 2015;359:218–225. doi:10.1016/j.canlet.2015.01.020.
   PubMed Web of Science ®Google Scholar
• Wang N, She J, Liu W, Shi J, Yang Q, Shi B, Hou P. Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients. Cell Cycle. 2015;14:732–743. doi:10.1080/15384101.2014.998047.
   PubMed Web of Science ®Google Scholar
• Flint AJ, Gebbink MF, Franza BR, Hill DE, Tonks NK. Multi-site phosphorylation of the protein tyrosine phosphatase, PTP1B: identification of cell cycle regulated and phorbol ester stimulated sites of phosphorylation. EMBO J. 1993;12:1937–1946. doi:10.1002/j.1460-2075.1993.tb05843.x.
   PubMed Web of Science ®Google Scholar
• Xu Q, Wu N, Li X, Guo C, Li C, Jiang B, Wang H, Shi D. Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway. Cell Death Dis. 2019;10:874. doi:10.1038/s41419-019-2073-4.
   PubMed Web of Science ®Google Scholar
• Carmona S, Brunel J-M, Bonier R, Sbarra V, Robert S, Borentain P, Lombardo D, Mas E, Gerolami R. A squalamine derivative, NV669, as a novel PTP1B inhibitor: in vitro and in vivo effects on pancreatic and hepatic tumor growth. Oncotarget. 2019;10:6651–6667. doi:10.18632/oncotarget.27286.
   PubMedGoogle Scholar
• Xie J, Qian Y-Y, Yang Y, Peng L-J, Mao J-Y, Yang M-R, Tian Y, Sheng J. Isothiocyanate from Moringa oleifera seeds inhibits the growth and migration of renal cancer cells by regulating the PTP1B-dependent Src/Ras/Raf/ERK signaling pathway. Front Cell Dev Biol. 2021;9:790618. doi:10.3389/fcell.2021.790618.
   PubMed Web of Science ®Google Scholar
• Braun K, Hölzl G, Soucek T, Geisen C, Möröy T, Hengstschläger M. Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation. Oncogene. 1998;17:2259–2269. doi:10.1038/sj.onc.1202145.
   PubMed Web of Science ®Google Scholar
• Cho Y-Y, Tang F, Yao K, Lu C, Zhu F, Zheng D, Pugliese A, Bode AM, Dong Z. Cyclin-dependent kinase-3-mediated c-Jun phosphorylation at Ser63 and Ser73 enhances cell transformation. Cancer Res. 2009;69:272–281. doi:10.1158/0008-5472.CAN-08-3125.
   PubMed Web of Science ®Google Scholar
• Zheng D, Cho Y-Y, Lau ATY, Zhang J, Ma W-Y, Bode AM, Dong Z. Cyclin-dependent kinase 3-mediated activating transcription factor 1 phosphorylation enhances cell transformation. Cancer Res. 2008;68:7650–7660. doi:10.1158/0008-5472.CAN-08-1137.
   PubMed Web of Science ®Google Scholar
• Xiao T, Zhu JJ, Huang S, Peng C, He S, Du J, Hong R, Chen X, Bode AM, Jiang W, et al. Phosphorylation of NFAT3 by CDK3 induces cell transformation and promotes tumor growth in skin cancer. Oncogene. 2017;36:2835–2845. doi:10.1038/onc.2016.434.
   PubMed Web of Science ®Google Scholar
• O’Donovan DS, MacFhearraigh S, Whitfield J, Swigart LB, Evan GI, Mc Gee MM. Sequential Cdk1 and Plk1 phosphorylation of protein tyrosine phosphatase 1B promotes mitotic cell death. Cell Death Dis. 2013;4:e468. doi:10.1038/cddis.2012.208.
   PubMed Web of Science ®Google Scholar
• Dubé N, Cheng A, Tremblay ML. The role of protein tyrosine phosphatase 1B in Ras signaling. Proc Natl Acad Sci USA. 2004;101:1834–1839. doi:10.1073/pnas.0304242101.
   PubMed Web of Science ®Google Scholar
• van den Heuvel S, Harlow E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science. 1993;262:2050–2054. doi:10.1126/science.8266103.
   PubMed Web of Science ®Google Scholar
• Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006;127:635–648. doi:10.1016/j.cell.2006.09.026.
   PubMed Web of Science ®Google Scholar
• Larsen MR, Thingholm TE, Jensen ON, Roepstorff P, Jørgensen TJD. Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol Cell Proteomics. 2005;4:873–886. doi:10.1074/mcp.T500007-MCP200.
   PubMed Web of Science ®Google Scholar
• Rappsilber J, Ishihama Y, Mann M. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal Chem. 2003;75:663–670. doi:10.1021/ac026117i.
   PubMed Web of Science ®Google Scholar
• Perez-Riverol Y, Bai J, Bandla C, García-Seisdedos D, Hewapathirana S, Kamatchinathan S, Kundu DJ, Prakash A, Frericks-Zipper A, Eisenacher M, et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50:D543–D552. doi:10.1093/nar/gkab1038.
   PubMed Web of Science ®Google Scholar
• Desta IT, Porter KA, Xia B, Kozakov D, Vajda S. Performance and its limits in rigid body protein-protein docking. Structure. 2020;28:1071–1081.e3. doi:10.1016/j.str.2020.06.006.
   PubMed Web of Science ®Google Scholar
• Kozakov D, Beglov D, Bohnuud T, Mottarella SE, Xia B, Hall DR, Vajda S. How good is automated protein docking? Proteins Struct Funct Bioinforma. 2013;81:2159–2166. doi:10.1002/prot.24403.
   PubMed Web of Science ®Google Scholar
• Vajda S, Yueh C, Beglov D, Bohnuud T, Mottarella SE, Xia B, Hall DR, Kozakov D. New additions to the ClusPro server motivated by CAPRI. Proteins Struct Funct Bioinforma. 2017;85:435–444. doi:10.1002/prot.25219.
   PubMed Web of Science ®Google Scholar
• Krieger E, Vriend G. YASARA View—molecular graphics for all devices—from smartphones to workstations. Bioinformatics. 2014;30:2981–2982. doi:10.1093/bioinformatics/btu426.
   PubMed Web of Science ®Google Scholar
• Krieger E, Vriend G. New ways to boost molecular dynamics simulations. J Comput Chem. 2015;36:996–1007. doi:10.1002/jcc.23899.
   PubMed Web of Science ®Google Scholar
• Vivar-Sierra A, Araiza-Macías MJ, Hernández-Contreras JP, Vergara-Castañeda A, Ramírez-Vélez G, Pinto-Almazán R, Salazar JR, Loza-Mejía MA. In silico study of polyunsaturated fatty acids as potential SARS-CoV-2 spike protein closed conformation stabilizers: epidemiological and computational approaches. Molecules. 2021;26:711. doi:10.3390/molecules26030711.
   PubMed Web of Science ®Google Scholar
• Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, Žídek A, Potapenko A, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583–589. doi:10.1038/s41586-021-03819-2.
   PubMed Web of Science ®Google Scholar
• Bartolomé RA, Martín-Regalado Á, Jaén M, Zannikou M, Zhang P, de los Ríos V, Balyasnikova IV, Casal JI. Protein tyrosine phosphatase-1B inhibition disrupts IL13Rα2-promoted invasion and metastasis in cancer cells. Cancers. 2020;12:500. doi:10.3390/cancers12020500.
   PubMed Web of Science ®Google Scholar
• Lantz KA, Hart SGE, Planey SL, Roitman MF, Ruiz-White IA, Wolfe HR, McLane MP. 2010 Inhibition of PTP1B by trodusquemine (MSI-1436) causes fat-specific weight loss in diet-induced obese mice. Obesity. 18(8):1516–1523.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408. doi:10.1006/meth.2001.1262.
   PubMed Web of Science ®Google Scholar